tradmap

WVE Earnings Wave Life Sciences Ltd.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$2 -$1 $0 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $57M $113M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$204M -$102M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$2 -$1 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $25M $49M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$69M -$20M $29M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–21 of 21
Q2 20262026-06-30-0.472026-07-3010-Q
Q1 20262026-03-31-0.132026-04-2810-Q
FY 20252025-12-31-1.212026-02-2610-K
Q3 20252025-09-30-0.922025-11-1010-Q
Q2 20262025-06-30-0.602026-07-3010-Q
Q1 20262025-03-31-0.292026-04-2810-Q
FY 20252024-12-31-0.702026-02-2610-K
Q3 20252024-09-30-0.972025-11-1010-Q
Q2 20252024-06-30-0.502025-07-3010-Q
Q1 20252024-03-31-0.242025-05-0810-Q
FY 20252023-12-31-0.542026-02-2610-K
Q3 20242023-09-30-0.392024-11-1210-Q
Q2 20242023-06-30-0.472024-08-0810-Q
Q1 20242023-03-31-0.272024-05-1010-Q
FY 20242022-12-31-2.052025-03-0410-K
Q3 20232022-09-30-1.602023-11-0910-Q
Q2 20232022-06-30-1.252023-08-0310-Q
Q1 20232022-03-31-0.622023-05-0310-Q
FY 20222021-12-31-2.362023-03-2310-K
Q3 20222021-09-30-1.752022-11-1010-Q
Q2 20222021-06-30-1.652022-08-1110-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.